Forensic Analysis · Health Care · as of Sep 24, 2026
Forte Biosciences Inc. Common Stock (FBRX)
A forensic read on Forte Biosciences Inc. Common Stock built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
-16.8
P / E (ttm)
-106.2%
ROE
$1.6B
Market cap
0.00%
Dividend yield
-99.8%
Revenue growth
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Forte Biosciences Inc. Common Stock's actual 10-K/10-Q/8-K filings?
Generate the AI investment read →No credit card · informational only, not investment advice · see the track record
← Browse all forensic stock analyses
Data from SEC EDGAR public filings · metrics as of Sep 24, 2026. Forensic signals flag probability, not certainty.